Corey Goodman

Chairman at Mindrythm

Health Technology

Network origin in Corey Goodman first degree

Entity	Entity type	Industry
NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. 6	Holding Company	Biotechnology	6
Mindrythm Mindrythm Medical SpecialtiesHealth Technology Mindrythm is a brain wellness company based in San Francisco, CA. Mindrythm develops medical technology to prevent neurological injury, with a focus on stroke prevention. The company's proprietary monitoring devices and communication platform aim to solve the triage problem in stroke, potentially saving more than 200,000 lives in 2022. The company was founded by John Keane and Paul Lovoi, with John Keane serving as the CEO since incorporation. 2	Holding Company	Medical Specialties	2
Alexo Therapeutics International Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. 1	Subsidiary	Pharmaceuticals: Major	1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Corey Goodman via their personal network

Company	Sector	Related people	Main position
University of California, Berkeley	College/University	Gerd Kochendoerfer Jaume Pons	Doctorate Degree Graduate Degree
FIBROGEN, INC.	Pharmaceuticals: Major	William Hodder Gerd Kochendoerfer	Corporate Officer/Principal Corporate Officer/Principal
BIOMARIN PHARMACEUTICAL INC.	Biotechnology	Joshua Grass	Public Communications Contact
ALX ONCOLOGY HOLDINGS INC.	Biotechnology	Jaume Pons	Founder
PellePharm, Inc. PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.	Biotechnology	Gerd Kochendoerfer	Chief Operating Officer
venBio Partners LLC venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California.	Investment Managers	Jaume Pons	Private Equity Investor
PFIZER, INC.	Pharmaceuticals: Major	Jaume Pons	Chief Tech/Sci/R&D Officer
Alx Oncology Ltd. Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin.	Pharmaceuticals: Major	Jaume Pons	Founder
ALX Oncology, Inc. ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons.	Pharmaceuticals: Major	Jaume Pons	Chief Executive Officer
Universitat Autònoma de Barcelona	College/University	Jaume Pons	Doctorate Degree
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA.	Biotechnology	Jaume Pons	Chief Tech/Sci/R&D Officer
Tallac Therapeutics, Inc. Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA.	Biotechnology	Jaume Pons	Director/Board Member
Sirpant Therapeutics		Jaume Pons	Director/Board Member
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California.	Investment Managers	Jaume Pons	Consultant / Advisor
3CC Management LLC 3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts.	Investment Managers	Kenneth Tsai	Private Equity Investor
Harvard Medical School	College/University	Kenneth Tsai	Graduate Degree
Massachusetts Institute of Technology	College/University	Kenneth Tsai	Doctorate Degree
Yale University	College/University	Kenneth Tsai	Undergraduate Degree
The State University of New York	College/University	Christopher Powala	Undergraduate Degree
California Polytechnic State University (San Luis Obispo)	College/University	Joshua Grass	Undergraduate Degree
Promedior, Inc. Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.	Medical Specialties	William Hodder	Corporate Officer/Principal
Vrolyk & Co.		Joshua Grass	Corporate Officer/Principal
CERUS CORPORATION	Medical Specialties	Joshua Grass	Chief Tech/Sci/R&D Officer
Modis Therapeutics, Inc. Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA.	Miscellaneous Commercial Services	Joshua Grass	Chief Executive Officer
Meves Pharmaceuticals, Inc. Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY.	Pharmaceuticals: Major	Joshua Grass	Chief Executive Officer
Escient Pharmaceuticals, Inc. Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA.	Biotechnology	Joshua Grass	Chief Executive Officer
University of Rochester Simon Business School	College/University	Joshua Grass	Masters Business Admin
Oakland University (Michigan)	College/University	William Hodder	Undergraduate Degree
Wyeth Laboratories, Inc.		Christopher Powala	Corporate Officer/Principal
The University of Chicago Booth School of Business	College/University	William Hodder	Masters Business Admin
PROTAGONIST THERAPEUTICS, INC.	Biotechnology	William Hodder	Corporate Officer/Principal
Vapogenix, Inc. Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX.	Medical/Nursing Services	William Hodder	Chief Executive Officer
Vicept Therapeutics, Inc. Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA.	Pharmaceuticals: Major	Christopher Powala	Founder
CollaGenex Pharmaceuticals, Inc. CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA.	Pharmaceuticals: Major	Christopher Powala	General Counsel
ACLARIS THERAPEUTICS, INC.	Pharmaceuticals: Major	Christopher Powala	Founder
H. Lee Moffitt Cancer Center & Research Institute, Inc. H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL.	Miscellaneous Commercial Services	Kenneth Tsai	Director/Board Member